| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | BRD-K78574327 | CTRPv2 | pan-cancer | AAC | 0.13 | 0.07 |
| mRNA | Cytarabine | CTRPv2 | pan-cancer | AAC | 0.052 | 0.07 |
| mRNA | necrosulfonamide | CTRPv2 | pan-cancer | AAC | 0.07 | 0.07 |
| mRNA | spautin-1 | CTRPv2 | pan-cancer | AAC | 0.068 | 0.07 |
| mRNA | semagacestat | CTRPv2 | pan-cancer | AAC | -0.068 | 0.07 |
| mRNA | carboplatin:etoposide (40:17 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.054 | 0.08 |
| mRNA | neratinib | CTRPv2 | pan-cancer | AAC | -0.064 | 0.08 |
| mRNA | GSK-J4 | CTRPv2 | pan-cancer | AAC | 0.19 | 0.08 |
| mRNA | BRD-K16147474 | CTRPv2 | pan-cancer | AAC | -0.071 | 0.08 |
| mRNA | RG-108 | CTRPv2 | pan-cancer | AAC | 0.065 | 0.08 |